Chulalongkorn closes vaccine trial applications early as enough people sign up

[Thaiger]

The Faculty of Medicine at Bangkok’s Chulalongkorn University has closed volunteer applications for its Covid-19 vaccine trials as enough people have already signed up. Nation Thailand reports that the Chula Vaccine Research Centre closed applications ahead of schedule as it already has enough volunteers. The Thai vaccine candidate, named ChulaCov19, is an mRNA vaccine, which is expected to begin second-phase trials by the end of this month. Participants in the trials must be between the ages of 56 and 75 with no underlying health conditions. They must also have never contracted Covid-19 or been vaccinated against the virus. Volunteers who […]

The post Chulalongkorn closes vaccine trial applications early as enough people sign up appeared first on Thaiger News.

Read the full story

[js89]

Quote

Nation Thailand reports that the vaccine is being developed with the support of the US academic who invented mRNA vaccine technology. Professor Drew Weissman from the University of Pennsylvania developed the vaccine from Covid-19’s genetic material, without the need to use any infection

This is a disservice to his colleague and collaborator Katalin Kariko, who started earlier and fought decades long scepticism from the academic establishment in her pursuit of an mRNA vaccine.